Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (42) clinical trials

The purpose of the study is to evaluate the efficacy and safety of intravenous (IV) ustekinumab in inducing clinical remission in subjects with moderately to severely active ulcerative colitis.

Phase

The purpose of the study is to assess the effect of Vedolizumab subcutaneously on clinical remission at Week 52 in subjects with moderately to severely active UC, who achieved a clinical response at Week 6, following the administration of Vedolizumab IV.

Phase

The purpose of the study is to determine the effect of Vedolizumab IV compared to adalimumab SC on achieving clinical remission in patients with Ulcerative Colitis, at Week 52.

Phase

Winthrop University Hospital’s Clinical Trials Center is seeking volunteers with moderately to severely active Ulcerative Colitis. The main purpose of this study is to see if an investigational medication is useful and safe for treating patients with moderately to severely active ulcerative colitis. Eligible participants will receive study-related medication and ...

Phase

The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).

Phase

The purpose of this study is to assess the effect of vedolizumab in the subcutaneous form.

Phase

To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active UC who achieved clinical response at Week 6 following administration of vedolizumab IV at Weeks 0 and 2.

Phase

A phase 3 research study of an oral investigational medication as induction and maintenance therapy for adults ages 18 to 75 with moderate to severe ulcerative colitis. Note, study participants may receive the investigational medication or placebo. For more information, please visit our study website at: www.TrueNorthStudy.com

Phase